Axsome Therapeutics, Inc. (0HKF.L)
| Previous close | 33.25 |
| Open | 33.11 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 33.11 - 33.11 |
| 52-week range | 33.11 - 33.11 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.07B |
| Beta (5Y monthly) | 2.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.77 |
| Earnings date | 28 Feb 2022 - 04 Mar 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Implied Volatility Surging for Axsome (AXSM) Stock Options
Investors need to pay close attention to Axsome (AXSM) stock based on the movements in the options market lately.
- Motley Fool
Why Axsome Therapeutics Stock Took a Step Backwards This Week
Shares of Axsome Therapeutics (NASDAQ: AXSM) lost 9.75% of their value through Thursday's closing bell this week, according to data from S&P Global Market Intelligence. The biotech's shares are currently well off of their 52-week highs due to a regulatory delay for its experimental major depressive disorder drug AXS-05. What's important to understand is that this regulatory hiccup reportedly centers around two issues with the company's analytical methods in the Chemistry, Manufacturing, and Controls section of the New Drug Application submitted to the Food and Drug Administration (FDA).
- Motley Fool
3 Biotech Stocks That Can Double Your Money, According to Wall Street
All three of these stocks could rise over 100% once stock-market sentiment falls in line with the opinions of investment-bank analysts.
